chr16-1219113-C-A
Variant names:
Variant summary
Our verdict is Benign. The variant received -11 ACMG points: 0P and 11B. BP4_StrongBP6_ModerateBP7BS2
The NM_021098.3(CACNA1H):c.6031C>A(p.Arg2011Arg) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000972 in 1,543,186 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.000013 ( 0 hom., cov: 34)
Exomes 𝑓: 0.0000093 ( 0 hom. )
Consequence
CACNA1H
NM_021098.3 synonymous
NM_021098.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.0520
Publications
3 publications found
Genes affected
CACNA1H (HGNC:1395): (calcium voltage-gated channel subunit alpha1 H) This gene encodes a T-type member of the alpha-1 subunit family, a protein in the voltage-dependent calcium channel complex. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization and consist of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. The alpha-1 subunit has 24 transmembrane segments and forms the pore through which ions pass into the cell. There are multiple isoforms of each of the proteins in the complex, either encoded by different genes or the result of alternative splicing of transcripts. Alternate transcriptional splice variants, encoding different isoforms, have been characterized for the gene described here. Studies suggest certain mutations in this gene lead to childhood absence epilepsy (CAE). [provided by RefSeq, Jul 2008]
CACNA1H Gene-Disease associations (from GenCC):
- hyperaldosteronism, familial, type IVInheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- childhood absence epilepsyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- epilepsy, childhood absence, susceptibility to, 6Inheritance: AD Classification: LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -11 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.65).
BP6
Variant 16-1219113-C-A is Benign according to our data. Variant chr16-1219113-C-A is described in ClinVar as [Benign]. Clinvar id is 2165839.Status of the report is criteria_provided_single_submitter, 1 stars.
BP7
Synonymous conserved (PhyloP=0.052 with no splicing effect.
BS2
High AC in GnomAdExome4 at 13 AD gene.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CACNA1H | ENST00000348261.11 | c.6031C>A | p.Arg2011Arg | synonymous_variant | Exon 34 of 35 | 1 | NM_021098.3 | ENSP00000334198.7 | ||
CACNA1H | ENST00000569107.6 | c.6046C>A | p.Arg2016Arg | synonymous_variant | Exon 33 of 34 | 1 | ENSP00000454990.2 | |||
CACNA1H | ENST00000711493.1 | c.6016C>A | p.Arg2006Arg | synonymous_variant | Exon 33 of 34 | ENSP00000518778.1 | ||||
CACNA1H | ENST00000565831.7 | c.6013C>A | p.Arg2005Arg | synonymous_variant | Exon 33 of 34 | 1 | ENSP00000455840.1 | |||
CACNA1H | ENST00000711450.1 | c.6013C>A | p.Arg2005Arg | synonymous_variant | Exon 34 of 35 | ENSP00000518762.1 | ||||
CACNA1H | ENST00000564231.6 | c.5998C>A | p.Arg2000Arg | synonymous_variant | Exon 34 of 35 | 1 | ENSP00000457555.2 | |||
CACNA1H | ENST00000638323.1 | c.5992C>A | p.Arg1998Arg | synonymous_variant | Exon 34 of 35 | 5 | ENSP00000492267.1 | |||
CACNA1H | ENST00000562079.6 | c.5980C>A | p.Arg1994Arg | synonymous_variant | Exon 33 of 34 | 1 | ENSP00000454581.2 | |||
CACNA1H | ENST00000711438.1 | c.5974C>A | p.Arg1992Arg | synonymous_variant | Exon 33 of 34 | ENSP00000518754.1 | ||||
CACNA1H | ENST00000711482.1 | c.6031C>A | p.Arg2011Arg | synonymous_variant | Exon 34 of 36 | ENSP00000518771.1 | ||||
CACNA1H | ENST00000711485.1 | c.5980C>A | p.Arg1994Arg | synonymous_variant | Exon 33 of 35 | ENSP00000518774.1 | ||||
CACNA1H | ENST00000711455.1 | c.5953C>A | p.Arg1985Arg | synonymous_variant | Exon 34 of 36 | ENSP00000518768.1 | ||||
CACNA1H | ENST00000711483.1 | c.6031C>A | p.Arg2011Arg | synonymous_variant | Exon 34 of 35 | ENSP00000518772.1 | ||||
CACNA1H | ENST00000621827.2 | n.6031C>A | non_coding_transcript_exon_variant | Exon 34 of 37 | 6 | ENSP00000518766.1 | ||||
CACNA1H | ENST00000637236.3 | n.*1950C>A | non_coding_transcript_exon_variant | Exon 33 of 34 | 5 | ENSP00000492650.2 | ||||
CACNA1H | ENST00000639478.1 | n.*1079C>A | non_coding_transcript_exon_variant | Exon 34 of 35 | 5 | ENSP00000491945.1 | ||||
CACNA1H | ENST00000640028.1 | n.*3849C>A | non_coding_transcript_exon_variant | Exon 34 of 35 | 5 | ENSP00000491488.1 | ||||
CACNA1H | ENST00000711442.1 | n.*5475C>A | non_coding_transcript_exon_variant | Exon 32 of 34 | ENSP00000518758.1 | |||||
CACNA1H | ENST00000711448.1 | n.*972C>A | non_coding_transcript_exon_variant | Exon 35 of 36 | ENSP00000518760.1 | |||||
CACNA1H | ENST00000711449.1 | n.*890C>A | non_coding_transcript_exon_variant | Exon 34 of 35 | ENSP00000518761.1 | |||||
CACNA1H | ENST00000711451.1 | n.*1610C>A | non_coding_transcript_exon_variant | Exon 35 of 36 | ENSP00000518763.1 | |||||
CACNA1H | ENST00000711452.1 | n.*698C>A | non_coding_transcript_exon_variant | Exon 35 of 36 | ENSP00000518764.1 | |||||
CACNA1H | ENST00000711453.1 | n.*665C>A | non_coding_transcript_exon_variant | Exon 35 of 36 | ENSP00000518765.1 | |||||
CACNA1H | ENST00000711484.1 | n.5980C>A | non_coding_transcript_exon_variant | Exon 33 of 35 | ENSP00000518773.1 | |||||
CACNA1H | ENST00000711486.1 | n.6031C>A | non_coding_transcript_exon_variant | Exon 34 of 37 | ENSP00000518775.1 | |||||
CACNA1H | ENST00000711487.1 | n.5998C>A | non_coding_transcript_exon_variant | Exon 34 of 36 | ENSP00000518776.1 | |||||
CACNA1H | ENST00000711488.1 | n.*1147C>A | non_coding_transcript_exon_variant | Exon 34 of 35 | ENSP00000518777.1 | |||||
CACNA1H | ENST00000637236.3 | n.*1950C>A | 3_prime_UTR_variant | Exon 33 of 34 | 5 | ENSP00000492650.2 | ||||
CACNA1H | ENST00000639478.1 | n.*1079C>A | 3_prime_UTR_variant | Exon 34 of 35 | 5 | ENSP00000491945.1 | ||||
CACNA1H | ENST00000640028.1 | n.*3849C>A | 3_prime_UTR_variant | Exon 34 of 35 | 5 | ENSP00000491488.1 | ||||
CACNA1H | ENST00000711442.1 | n.*5475C>A | 3_prime_UTR_variant | Exon 32 of 34 | ENSP00000518758.1 | |||||
CACNA1H | ENST00000711448.1 | n.*972C>A | 3_prime_UTR_variant | Exon 35 of 36 | ENSP00000518760.1 | |||||
CACNA1H | ENST00000711449.1 | n.*890C>A | 3_prime_UTR_variant | Exon 34 of 35 | ENSP00000518761.1 | |||||
CACNA1H | ENST00000711451.1 | n.*1610C>A | 3_prime_UTR_variant | Exon 35 of 36 | ENSP00000518763.1 | |||||
CACNA1H | ENST00000711452.1 | n.*698C>A | 3_prime_UTR_variant | Exon 35 of 36 | ENSP00000518764.1 | |||||
CACNA1H | ENST00000711453.1 | n.*665C>A | 3_prime_UTR_variant | Exon 35 of 36 | ENSP00000518765.1 | |||||
CACNA1H | ENST00000711488.1 | n.*1147C>A | 3_prime_UTR_variant | Exon 34 of 35 | ENSP00000518777.1 | |||||
CACNA1H | ENST00000711456.1 | c.5887+462C>A | intron_variant | Intron 33 of 33 | ENSP00000518769.1 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152158Hom.: 0 Cov.: 34 show subpopulations
GnomAD3 genomes
AF:
AC:
2
AN:
152158
Hom.:
Cov.:
34
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0000755 AC: 11AN: 145658 AF XY: 0.0000641 show subpopulations
GnomAD2 exomes
AF:
AC:
11
AN:
145658
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000935 AC: 13AN: 1390910Hom.: 0 Cov.: 34 AF XY: 0.00000584 AC XY: 4AN XY: 685250 show subpopulations
GnomAD4 exome
AF:
AC:
13
AN:
1390910
Hom.:
Cov.:
34
AF XY:
AC XY:
4
AN XY:
685250
show subpopulations
African (AFR)
AF:
AC:
0
AN:
31470
American (AMR)
AF:
AC:
0
AN:
35386
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
24846
East Asian (EAS)
AF:
AC:
12
AN:
35574
South Asian (SAS)
AF:
AC:
0
AN:
78784
European-Finnish (FIN)
AF:
AC:
0
AN:
46632
Middle Eastern (MID)
AF:
AC:
0
AN:
5660
European-Non Finnish (NFE)
AF:
AC:
1
AN:
1074888
Other (OTH)
AF:
AC:
0
AN:
57670
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
1
2
4
5
6
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152276Hom.: 0 Cov.: 34 AF XY: 0.0000134 AC XY: 1AN XY: 74460 show subpopulations
GnomAD4 genome
AF:
AC:
2
AN:
152276
Hom.:
Cov.:
34
AF XY:
AC XY:
1
AN XY:
74460
show subpopulations
African (AFR)
AF:
AC:
0
AN:
41542
American (AMR)
AF:
AC:
0
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3470
East Asian (EAS)
AF:
AC:
2
AN:
5168
South Asian (SAS)
AF:
AC:
0
AN:
4830
European-Finnish (FIN)
AF:
AC:
0
AN:
10620
Middle Eastern (MID)
AF:
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
AC:
0
AN:
68024
Other (OTH)
AF:
AC:
0
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.425
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Idiopathic generalized epilepsy;C4310756:Hyperaldosteronism, familial, type IV Benign:1
Dec 05, 2021
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.